Discover nxt-level protection
Nobivac® NXT (next) are the first and only companion animal vaccines to use revolutionary RNA particle technology
The Nobivac® NXT advantage
See how our groundbreaking RNA particle technology delivers NXT-level immunity to your patients
Benefits of NXT-level protection
Smaller
dose
A low-volume 0.5-mL dose for a more gentle vaccine experience
No extraneous
material
NXT-level protection in a preservative-free, adjuvant-free, thimerosal-free formulation
Targeted and
efficient
Delivers the desired viral sequence to dendritic cells for an enhanced, precise immune response
Safety and efficacy
without compromise
Self-amplification triggers a robust antibody and cellular immune response without the use of an adjuvant or live organisms
NXT level immunity
- Deliver an unparalleled combination of optimal safety and robust efficacy
- NXT-level RNA particle technology enhances the body’s natural processes to stimulate comprehensive immunity
- Adjuvant-free, preservative-free, low-volume, 0.5-mL dose
- Total peace of mind for pet owners and you
Revolutionary RNA particle technology
- Delivers the RNA sequence of a pathogen’s specific gene of interest (GOI) in a targeted way to the dendritic cell
- The GOI is unpackaged and, for a limited time, makes multiple copies of itself
- The copies of the GOI are translated into large amounts of antigen, which stimulates a broad and balanced immune response
Related Products
Nobivac® NXT Canine Flu H3N2
A groundbreaking new way to safeguard dogs against the ongoing threat of canine flu:
- First and only canine flu vaccine built on RNA particle technology
- RNA particles stimulate the immune system to attack the H3N2 virus without the use of adjuvants or live organisms
- Enhances the body’s natural processes to induce comprehensive immunity
- A low-volume 0.5-mL dose provides a more gentle vaccine experience
- NXT-level protection in a preservative-free, adjuvant-free, thimerosal-free formulation
